VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PTGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PTGXProtagonist Therapeutics, Inc.
$140.06$9.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPTGXQuarterly Balance Sheet

Protagonist Therapeutics, Inc. (PTGX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Protagonist Therapeutics, Inc. (PTGX) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

PTGX Balance Sheet

Quarterly statement

PTGX Balance Sheet

Protagonist Therapeutics, Inc. (PTGX) balance sheet — 12-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets807.15M613.46M577.57M586.42M602.53M605.86M591.64M476.77M570.92M627.55M355.58M324.88M316.94M235.74M243.08M276.62M304.3M341.52M340.74M327.69M
Cash & Short-Term Investments782.58M547.79M567.36M576.12M570.47M574.36M418.91M468.72M564M322.63M341.62M320.75M313.4M230.76M237.35M267.44M291.89M305.29M326.9M314.3M
Cash Only420.08M193.71M128.39M113.71M168.54M139.65M97.25M131.12M355.64M172.57M186.73M230.53M235.38M127.69M125.74M152.82M120.24M98.48M123.67M120.54M
Short-Term Investments362.5M354.07M438.97M462.4M401.92M434.71M321.66M337.6M208.35M150.07M154.89M90.22M78.02M103.07M111.61M114.62M171.65M206.81M203.24M193.76M
Accounts Receivable13.42M57.12M4.5M583K27.97M27.09M168.49M2.67M1.37M300.4M10.33M65K50K51K52K620K3.36M28.5M5.33M4.51M
Days Sales Outstanding15.0349.1931.42278.75451.71310.7646.1439.743.3K55.467.97-----1.69K59.252.5464.24
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets3.37M004.74M0000000000000000
Total Non-Current Assets78.4M84M92.32M115.26M115.48M136.27M153.08M127.09M43.7M1.72M2.37M5.13M3.52M4.12M4.85M5.56M6.21M6.77M6.96M45.49M
Property, Plant & Equipment3.46M11.17M11.69M12.27M12.7M12.53M12.61M12.3M12.03M1.5M2.15M2.92M3.3M3.9M4.63M5.33M5.99M6.55M6.73M7.09M
Fixed Asset Turnover29.20x4.93x0.62x0.38x0.44x2.25x13.70x0.38x0.62x139.82x23.65x-----0.14x3.87x1.25x1.56x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments66.88M72.55M78.92M102.7M102.49M123.52M140.25M114.56M31.45M001.99M000000038.17M
Other Non-Current Assets8.06M288K0287K290K225K225K225K225K225K225K225K225K225K225K225K225K225K225K225K
Total Assets885.54M697.46M669.89M701.69M718.01M742.13M744.73M603.86M614.63M629.28M357.95M330.02M320.47M239.86M247.93M282.17M310.51M348.3M347.69M373.18M
Asset Turnover0.27x0.08x0.01x0.01x0.01x0.04x0.25x0.01x0.01x0.52x0.17x-----0.00x0.07x0.02x0.03x
Asset Growth %23.33%-6.02%-10.05%16.2%16.82%17.93%108.05%82.98%91.79%162.35%44.38%16.95%3.21%-31.13%-28.69%-24.39%-23.18%16.85%7.16%71.72%
Total Current Liabilities37.18M34.55M45.44M44.94M35.51M35.11M47.4M44.58M41.58M39.91M21.27M27.87M26.4M23.23M31.18M36.75M40.09M43.46M44.02M39.16M
Accounts Payable3.46M8.44M5.34M5.65M3.25M2.92M1.61M3.05M3.63M3.51M772K1.25M4.57M4.02M3.64M4.71M1.41M7.16M1.6M706K
Days Payables Outstanding-1.52K--------------462.61473.18129.52-
Short-Term Debt002.28M2.23M00510K0000000000000
Deferred Revenue (Current)9.66M6.28M9.55M14.2M14.69M16.89M18.89M19.7M20.12M16.13M03K10K22K69K32K80K1.15M2.5M3.36M
Other Current Liabilities04.23M15.51M15.34M5.01M2.9M12.62M8.15M5.45M2.46M6.79M4.53M3.63M2.08M4.97M4.74M4.39M2.64M7.13M4.72M
Current Ratio21.71x17.76x12.71x13.05x16.97x17.26x12.48x10.70x13.73x15.72x16.71x11.66x12.01x10.15x7.80x7.53x7.59x7.86x7.74x8.37x
Quick Ratio21.71x17.76x12.71x13.05x16.97x17.26x12.48x10.70x13.73x15.72x16.71x11.66x12.01x10.15x7.80x7.53x7.59x7.86x7.74x8.37x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities6.82M7.44M9.74M11.31M14.48M17.97M22.03M27.36M31.73M28.92M000462K1.14M1.8M2.45M3.06M3.66M4.36M
Long-Term Debt00000000000000000000
Capital Lease Obligations6.82M7.44M8.04M8.52M9.11M9.79M10.36M10.86M10.97M0000462K1.14M1.8M2.45M3.06M3.66M4.24M
Deferred Tax Liabilities001.71M0000000221K000000000
Other Non-Current Liabilities0002.79M5.38M8.18M11.68M16.51M00-221K00000000121K
Total Liabilities44M41.99M55.19M56.25M49.99M53.08M69.43M71.94M73.31M68.83M21.27M27.87M26.4M23.69M32.32M38.56M42.53M46.52M47.67M43.52M
Total Debt9.22M9.78M10.32M10.75M11.28M11.36M10.87M10.9M10.97M462K1.14M1.8M2.45M3.06M3.66M4.24M4.8M5.34M5.86M6.26M
Net Debt-410.86M-183.94M-118.07M-102.96M-157.26M-128.29M-86.38M-120.22M-344.67M-172.11M-185.59M-228.72M-232.94M-124.63M-122.09M-148.58M-115.44M-93.14M-117.81M-114.28M
Debt / Equity0.01x0.01x0.02x0.02x0.02x0.02x0.02x0.02x0.02x0.00x0.00x0.01x0.01x0.01x0.02x0.02x0.02x0.02x0.02x0.02x
Debt / EBITDA0.06x-----0.09x--0.00x0.05x---------
Net Debt / EBITDA-2.49x------0.68x---0.83x-7.77x---------
Interest Coverage--------------------
Total Equity841.54M655.47M614.71M645.44M668.02M689.05M675.29M531.91M541.32M560.44M336.68M302.15M294.07M216.17M215.61M243.62M267.98M301.78M300.02M329.66M
Equity Growth %25.98%-4.87%-8.97%21.34%23.4%22.95%100.58%76.04%84.08%159.26%56.15%24.03%9.74%-28.37%-28.14%-26.1%-25.03%16.37%7.3%94.39%
Book Value per Share11.859.309.6710.1210.5210.9410.178.618.838.815.455.115.184.274.384.965.466.196.236.87
Total Shareholders' Equity841.54M655.47M614.71M645.44M668.02M689.05M675.29M531.91M541.32M560.44M336.68M302.15M294.07M216.17M215.61M243.62M267.98M301.78M300.02M329.66M
Common Stock1K1K1K1K1K1K1K1K1K1K1K1K1K1K000000
Retained Earnings-304.04M-466.89M-470.67M-426.29M-386.95M-352.18M-340.52M-472.2M-438.99M-408.37M-615.71M-643.04M-608.94M-570.48M-536.75M-502.56M-471.33M-430.29M-409.36M-372.45M
Treasury Stock00000000000000000000
Accumulated OCI-828K-269K641K525K-15K85K-82K1.34M-249K-229K-105K-170K-198K-122K-359K-480K-720K-472K-299K-204K
Minority Interest00000000000000000000